Amanote Research

Amanote Research

    RegisterSign In

Brachyury, a Vaccine Target, Is Overexpressed in Triple-Negative Breast Cancer

Endocrine-Related Cancer - United Kingdom
doi 10.1530/erc-16-0037
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
Date

October 1, 2016

Authors
Duane H HamiltonMario RoselliPatrizia FerroniLeopoldo CostarelliFrancesco CavaliereMariateresa TaffuriClaudia PalenaFiorella Guadagni
Publisher

Bioscientifica


Related search

Development of a Vaccine Targeting Triple-Negative Breast Cancer

2013English

Estrogen Receptor-Beta Is a Potential Target for Triple Negative Breast Cancer Treatment

Oncotarget
Oncology
2018English

Mesothelin, a Novel Immunotherapy Target for Triple Negative Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

ICAM-1 as a Molecular Target for Triple Negative Breast Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2014English

Triple-Negative Breast Cancer

2018English

Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer

Scientific Reports
Multidisciplinary
2019English

Identification of New Candidate Therapeutic Target Genes in Triple-Negative Breast Cancer

Genes and Cancer
Cancer ResearchGenetics
2012English

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Breast Disease
MedicineCancer ResearchOncology
2011English

A Review of Triple-Negative Breast Cancer

Cancer Control
MedicineOncologyHematology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy